Cargando…
38P Impact of 1-year COVID-19 pandemic in patients with ovarian carcinoma treated with chemotherapy based on a global data network
Autores principales: | Manso Sanchez, L.M., Madariaga Urrutia, A., Hernández-Ibarburu, G., Sanchez Bayona, R., Tolosa Ortega, P., Lema Roso, L., Alva, M., Modrego, A., Serrano, P., Paz-Ares, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212682/ http://dx.doi.org/10.1016/j.annonc.2022.04.056 |
Ejemplares similares
-
Analysis of the association of HER-2 low carcinomas and PAM50 assay in hormone receptor positive early-stage breast cancer
por: Terán, Santiago, et al.
Publicado: (2023) -
Digging into phenotype change in mismatch repair deficient endometrial carcinoma and treatment with immune checkpoint inhibition, a case report
por: Rey-Cárdenas, Macarena, et al.
Publicado: (2023) -
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story
por: García-Cano, Jesús, et al.
Publicado: (2016) -
Genomic landscape and immune-related gene expression profiling of epithelial ovarian cancer after neoadjuvant chemotherapy
por: Lodewijk, I., et al.
Publicado: (2022) -
Long-term effect of chemotherapy after ovarian decortication on the ovarian function in women surviving cancer
por: Ortiz, Ester, et al.
Publicado: (2023)